Thrivent Financial for Lutherans Has $4.23 Million Holdings in Tema Oncology ETF $CANC

Thrivent Financial for Lutherans decreased its position in shares of Tema Oncology ETF (NASDAQ:CANC) by 84.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 147,472 shares of the company’s stock after selling 810,003 shares during the period. Thrivent Financial for Lutherans owned about 0.05% of Tema Oncology ETF worth $4,233,000 at the end of the most recent reporting period.

Separately, Jane Street Group LLC acquired a new position in shares of Tema Oncology ETF in the 1st quarter worth approximately $213,000.

Tema Oncology ETF Price Performance

CANC stock opened at $36.58 on Friday. The business has a fifty day moving average price of $35.58 and a 200 day moving average price of $31.29. Tema Oncology ETF has a fifty-two week low of $20.10 and a fifty-two week high of $37.51. The stock has a market capitalization of $145.95 million, a price-to-earnings ratio of 20.39 and a beta of 1.00.

Tema Oncology ETF Dividend Announcement

The firm also recently announced an annual dividend, which was paid on Thursday, December 11th. Stockholders of record on Wednesday, December 10th were paid a $0.0196 dividend. The ex-dividend date was Wednesday, December 10th. This represents a dividend yield of 6.0%.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.